In Discussion With Medicines For Europe: Bracing For US Tariffs And Embracing Ukraine
Ukraine’s Integration Should Follow Tested Processes, But Needs Time And Resources
Tariffs, international cooperation, and war: the off-patent industry is not immune to the political issues raging across the globe. Medicines for Europe’s Adrian van den Hoven and Beata Stepniewska spoke with Generics Bulletin about what these developments mean for the sector.
